|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Taking a VC Approach to Charity, Greylock Veteran’s Alzheimer’s Research Foundation “Dares to Be Great”
|
Erin Kutz |
08/25/10 |
Boston
|
|
Montgomery Says Goodbye Gilead, Kaleetan’s Plan to Be the Next Dendreon, Calypso’s CEO Exit, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/12/10 |
Seattle
|
|
Alectos Snags Merck Deal
|
Luke Timmerman |
08/11/10 |
Seattle
|
|
BrainCells Inc. Buys Neuro Drug
|
Luke Timmerman |
08/04/10 |
San Diego
|
|
Immune Design Pockets $32M, InDi Nails $10M, SonoSite Looks Inside My Carotids, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/29/10 |
Seattle
|
|
Adeona gets $1M from Seaside 88
|
Howard Lovy |
07/06/10 |
Detroit
|
|
iPierian, With Harvard Science and Kleiner Perkins Cash, Pursues Stem Cells to Make Drugs
|
Luke Timmerman |
06/17/10 |
San Francisco
|
|
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News
|
Erin Kutz |
05/07/10 |
Boston
|
|
Link Medicine Ups Third Round to $45M, Taking Aim at Alzheimer’s and Parkinson’s
|
Ryan McBride |
05/04/10 |
Boston
|
|
Proteostasis, with San Diego Roots and Boston Home, Seeks Edge in Alzheimer’s and Parkinson’s
|
Luke Timmerman |
05/03/10 |
Boston
|
|
Sage Bionetworks On a Roll, Allon’s Foray into Alzheimer’s, Frazier Bets on Antibiotics, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/08/10 |
Seattle
|
|
Allon Treads Into the Great Unknown, Alzheimer’s Disease, With New Kind of Drug
|
Luke Timmerman |
04/06/10 |
Seattle
|
|
Lantheus Medical Imaging Stakes Future on Innovation After Generic Hit to Key Product
|
Ryan McBride |
02/16/10 |
Boston
|
|
BrainCells Inc. Maps Out Next Steps for Novel Depression Drug
|
Luke Timmerman |
02/02/10 |
San Diego
|
|
Quanterix CEO Sets Sight on Early Detection of Cancer, Neurological Diseases in the Blood
|
Luke Timmerman |
01/19/10 |
Boston
|
|
Sage Bionetworks Strikes Deal With Pfizer to Find Cancer Drug Targets
|
Luke Timmerman |
01/11/10 |
Seattle
|
|
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key
|
Luke Timmerman |
10/18/09 |
National
|
|
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News
|
Gregory T. Huang |
10/14/09 |
Seattle
|
|
Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
08/13/09 |
San Diego
|
|
Ichor Gets $3.3M Alzheimer’s Grant
|
Bruce V. Bigelow |
08/06/09 |
San Diego
|
|
Protecting America’s Leadership in Biotech Discovery
|
James N. Thomas |
08/06/09 |
Seattle
|
|
No More Tears: Avanir Investors Await Trial Results on Emotional Outburst Drug
|
Denise Gellene |
07/23/09 |
San Diego
|
|
Targeted Genetics Faces Extinction, Cell Therapeutics Unloads Debt, Dendreon Raises $221M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/14/09 |
Seattle
|
|
Epix Seeks Strategic Alternatives
|
Luke Timmerman |
05/12/09 |
Boston
|
|
ProteoTech Raises $519K
|
Luke Timmerman |
05/11/09 |
Seattle
|
|
Acadia Shares Soar on Alliance With Biovail for Parkinson’s Psychosis Drug
|
Luke Timmerman |
05/04/09 |
San Diego
|
|
TargAnox Launches with $5.1M Series A Round, Targeting Oxidative Stress to Treat Diseases
|
Ryan McBride |
03/30/09 |
Boston
|
|
Epix Pharma Appoints Gamzu CEO
|
Ryan McBride |
03/05/09 |
Boston
|
|
Page 2 of
3 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.